Brind.

UBS analysts cut price targets following mixed results reported by Clover Health, a health insurance provider.

2 reports, 1 independent Updated Sep 10

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

UBS analysts cut price targets following mixed results reported by Clover Health, a health insurance provider.

Who's involved

What this event is mainly about

UBS Clover Health

Keep exploring

The entities involved

UBS
Swiss multinational investment bank and financial services company
- The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
- Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25
Clover Health
U.S. healthcare company
- Clover Health CFO Peter Kuipers discussed the benefit expense ratio with UBS analysts on August 13, 2025.Sun 06:30
- Trump's tariff plan caused markets to tank, impacting Donnelley Financial Solutions.Sun 03:13

Related events

MiniMed Group received multiple target price increases from UBS, Morgan Stanley, and Deutsche Bank, and submitted a product to the FDA.Sep 22

Coverage

Newest first; wire copies grouped

Aug 7StockStoryWhy Clover Health (CLOV) Stock Is Nosediving Shares of health insurance company Clover Health (NASDAQ:CLOV) fell 20.3% in the afternoon session after the company reported mixed second-quarter results

1 more outlet ran the same wire story

Sep 10financialcontent.com